News

In the News

In partnership with our network partners, together, we have shared research on real-world treatment patterns in breast and non-small cell lung cancer.

View Syapse Press Kit

Hero News

Press Releases

12/05/2023

Syapse and FDA Extend Collaboration to Advance the Use of Real-World Data (RWD) and Inform Regulatory Science in Oncology

By Devon Hellman

SAN FRANCISCO, December 5, 2023 – Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, and the FDA Oncology Center of Excellence (OCE) renewed a four-year agreement to collaboratively develop and implement specific research projects to advance the use o…

Read

03/14/2023

Custom Research Presented at AMIA Informatics Summit Reveals Promising Findings for Healthcare Innovation

By Antoinette Cummins

SAN FRANCISCO, March 14, 2023 – Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced two new studies focused on developing drug ontologies to support real-world evidence generation and the use of machine learning to predict time to diagnosis.…

Read

09/15/2022

Syapse Enters Collaboration with Merck Using Real-World Evidence to Better Understand Cancers

By Devon Hellman

SAN FRANCISCO, NEW YORK, September 15, 2022 — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, has entered a collaboration with Merck, known as MSD, outside the United States and Canada, to leverage Syapse’s leading real-world evidence solutions designed to improve outcomes for cancer patients.

Read

Load more

Let's chat.

If you’d like to learn more about Syapse, tell us a little about yourself and we will reach out as soon as possible.